Skip to main content
. 2023 Feb 23;12(2):286–299. doi: 10.21037/tau-22-872

Figure 1.

Figure 1

miR-93-5p had significant clinical relevance and differential expression in BLCA. (A) The online website based on the TCGA database selected 144 survival-related DEG, 155 clinical stage-related genes, and 25 genes with the most significant expression differences. These genes intersected with the 25 genes that were most significantly elevated in exosomes in patients with BLCA. (B) The expression of miR-93-5p in different cancer and normal tissues in TCGA database. (C) The expression of miR-93-5p in BLCA and paracancerous tissues in TCGA database. (D) The expression of miR-93-5p in tumor and paracancerous tissues in 25 paired samples collected by our team. ***, P<0.001. TCGA, The Cancer Genome Atlas; BLCA, bladder cancer; DEG, differentially expressed genes; RPKM, reads per kilobase per million mapped reads; RPM, reads per million mapped reads.